Latest News
Voranigo Listed on the PBS: A Landmark Step Forward for Australians with IDH-Mutant Brain Tumours
Australians living with IDH-mutant astrocytoma and oligodendroglioma now have subsidised access to Voranigo (vorasidenib), following its listing on the Pharmaceutical Benefits Scheme (PBS) from 1 August 2026. The Australian Government has described Voranigo as the first new treatment in 20 years for these rare brain cancers – marking an important and long-awaited development for patients and families who have faced limited treatment options.
A temporary pause of the BTAA Helpline Support Service
The BTAA Helpline service to callers requesting support for brain tumours and related neurological issues will be temporarily paused for a period of review and reassessment. While we are unable to take your call during this period, we wish to redirect your concerns or questions to a dedicated and appropriately resourced agency able to provide advice and support for your situation.
Vale Professor Richard Scolyer AO
BTAA shares this statement on behalf of BTAA and the Australian Brain Tumour Collaborative (ABTC). Today, on World Brain Tumour Awareness Day, we honour the life and legacy of Professor Richard Scolyer AO — a giant of Australian science, a courageous patient, and an enduring champion for the brain cancer community.
BTAA Board Announcement – May 2026
Brain Tumour Alliance Australia is pleased to announce the appointment of its new Board, bringing together leaders in governance, advocacy, research...
Head to the Hill – October 2025
Head to the Hill 2025 saw patients, carers, clinicians and researchers come together to share their stories and advocate directly to federal MPs about the urgent needs of the brain tumour community. From personal stories, calls for funding and support from MPs, the day was full of powerful speeches and insights. Keynote speakers included Professor Richard Scolyer, Gail O’Brien and the Hon Mark Butler, Minister for Health.
New Research Into Brain Cancer’s Impact on Society
BTAA announces new research into the staggering economic burden of Brain Cancer on society, detailing the burden of disease and outlining key initiatives in research and support that can make a difference.
Monash University. We want to hear your story!
Are you a parent, caregiver, or young person with experience of paediatric low-grade glioma (pLGG) in Australia?